HYPHENS PHARMA revenue for the last year amounted to 170.59 M SGD, the most of which — 102.19 M SGD — came from its highest performing source at the moment, Specialty Pharma Principals, the year earlier bringing 95.66 M SGD. The greatest contribution to the revenue figure was made by Singapore — last year it brought HYPHENS PHARMA 85.00 M SGD, and the year before that — 84.55 M SGD.